Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation

NCT04558333 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT04558333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
Lead sponsor
University Hospital, Antwerp
Phase
Observational
Overall status
Terminated
Start date
October 28, 2019
Completion date
February 28, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant failure and rejection, primary graft dysfunction